Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1972 Jan 1;135(1):68–80. doi: 10.1084/jem.135.1.68

GENETIC POLYMORPHISM IN HUMAN GLYCINE-RICH BETA-GLYCOPROTEIN

Chester A Alper 1, Thomas Boenisch 1, Lillian Watson 1
PMCID: PMC2139116  PMID: 4109808

Abstract

Extensive polymorphism of glycine-rich β-glycoprotein (GBG) was found in human sera. In all instances, GBG consisted of at least five components on electrophoresis. Patterns were such that they provided evidence for four alleles (at a locus designated Gb) which were expressed as autosomal codominant traits. GbS and GbF were found in all populations but with different frequencies, Gb F1 was found in Negroes, and Gb S1 was found in Caucasians. From electrophoretic studies of GBG, evidence was obtained that suggested that the GBG molecule was a tetramer consisting of A and B subunits in a proportion of about 1.6:1. The genetically controlled differences in GBG embodied in the Gb system indicated the presence of a third moiety of the molecule (C), possibly a polypeptide subunit. Electrophoretic studies of fragments from defined types of GBG suggested that GBG cleavage induced by complement or properdin activation in serum occurred through this C moiety, since two variants were detectable in one fragment and two were found in the other fragment. On comparison of fetal-maternal Gb types, approximately one-half the pairs showed differences. This indicated that GBG did not cross the placental barrier.

Full Text

The Full Text of this article is available as a PDF (633.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. APPELLA E., MARKERT C. L. Dissociation of lactate dehydrogenase into subunits with guanidine hydrochloride. Biochem Biophys Res Commun. 1961 Nov 20;6:171–176. doi: 10.1016/0006-291x(61)90123-1. [DOI] [PubMed] [Google Scholar]
  2. Abramson N., Alper C. A., Lachmann P. J., Rosen F. S., Jandl J. H. Deficiency of C3 inactivator in man. J Immunol. 1971 Jul;107(1):19–27. [PubMed] [Google Scholar]
  3. Alper C. A., Abramson N., Johnston R. B., Jr, Jandl J. H., Rosen F. S. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest. 1970 Nov;49(11):1975–1985. doi: 10.1172/JCI106417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alper C. A., Johnson A. M. Immunofixation electrophoresis: a technique for the study of protein polymorphism. Vox Sang. 1969 Nov;17(5):445–452. doi: 10.1111/j.1423-0410.1969.tb00414.x. [DOI] [PubMed] [Google Scholar]
  5. Alper C. A., Propp R. P. Genetic polymorphism of the third component of human complement (C'3). J Clin Invest. 1968 Sep;47(9):2181–2191. doi: 10.1172/JCI105904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Alper C. A., Robin N. I., Refetoff S. Genetic polymorphism of rhesus thyroxine-binding prealbumin: evidence for tetrameric structure in primates. Proc Natl Acad Sci U S A. 1969 Jul;63(3):775–781. doi: 10.1073/pnas.63.3.775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BLUM L., PILLEMER L., LEPOW I. H. The properdin system and immunity. XIII. Assay and properties of a heat-labile serum factor (factor B) in the properdin system. Z Immun exp ther. 1959 Oct-Nov;118:349–357. [PubMed] [Google Scholar]
  8. Bernstein R. S., Robbins J., Rall J. E. Polymorphism of monkey thyroxin-binding prealbumin (TBPA): mode of inheritance and hybridization. Endocrinology. 1970 Feb;86(2):383–390. doi: 10.1210/endo-86-2-383. [DOI] [PubMed] [Google Scholar]
  9. Boenisch T., Alper C. A. Isolation and properties of a glycine-rich beta-glycoprotein of human serum. Biochim Biophys Acta. 1970 Dec 22;221(3):529–535. doi: 10.1016/0005-2795(70)90224-2. [DOI] [PubMed] [Google Scholar]
  10. Boenisch T., Alper C. A. Isolation and properties of a glycine-rich gamma-glycoprotein of human serum. Biochim Biophys Acta. 1970 Jul 27;214(1):135–140. doi: 10.1016/0005-2795(70)90077-2. [DOI] [PubMed] [Google Scholar]
  11. Goodkofsky I., Lepow I. H. Functional relationship of factor B in the properdin system to C3 proactivator of human serum. J Immunol. 1971 Oct;107(4):1200–1204. [PubMed] [Google Scholar]
  12. Haupt H., Heide K. Ioslierung und Eigenschaften eines beta 2-Glykoproteins aus Humanserum. Clin Chim Acta. 1965 Oct;12(4):419–424. doi: 10.1016/0009-8981(65)90130-0. [DOI] [PubMed] [Google Scholar]
  13. Johnson A. M., Schmid K., Alper C. A. Inheritance of human alpha-1-acid glycoprotein (orosomucoid) variants. J Clin Invest. 1969 Dec;48(12):2293–2299. doi: 10.1172/JCI106195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. LAURELL C. B. ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS. Anal Biochem. 1965 Feb;10:358–361. doi: 10.1016/0003-2697(65)90278-2. [DOI] [PubMed] [Google Scholar]
  15. Laurell C. B., Niléhn J. E. A new type of inherited serum albumin anomaly. J Clin Invest. 1966 Dec;45(12):1935–1945. doi: 10.1172/JCI105498. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Markert C. L. Lactate Dehydrogenase Isozymes: Dissociation and Recombination of Subunits. Science. 1963 Jun 21;140(3573):1329–1330. doi: 10.1126/science.140.3573.1329. [DOI] [PubMed] [Google Scholar]
  17. Markert C. L. The molecular basis for isozymes. Ann N Y Acad Sci. 1968 Jun 14;151(1):14–40. doi: 10.1111/j.1749-6632.1968.tb11876.x. [DOI] [PubMed] [Google Scholar]
  18. PENSKY J., WURZ L., PILLEMER L., LEPOW I. H. The properdin system and immunity. XII. Assay, properties and partial purification of a hydrazine-sensitive serum factor (factor A) in the properdin system. Z Immun exp ther. 1959 Oct-Nov;118:329–348. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES